Greg Frank is Director, Global Public Policy with MSD, where he leads global antimicrobial resistance (AMR) policy. Previously Dr. Frank served as Senior Director, Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), where he led several infectious diseases policy issues, including AMR and vaccine regulatory policy. Prior to BIO, Dr. Frank led science and diagnostics policy as Program Officer for Science and Research policy at the Infectious Diseases Society of America (IDSA).
Dr. Frank serves on the U.S. Presidential Advisory Committee on Antibiotic Resistant Bacteria (PACCARB), the Leadership Council of the National Institute of Antimicrobial Resistant Research and Education (NIAMREE), and the expert advisory committee for the Partnership to Fight Infectious Diseases. He has previously joined expert advisory committees of the Access to Medicines Foundation AMR Benchmark, the Global AMR R&D Hub, and the Duke-Margolis Center for Health Policy Antimicrobial Incentives & Payment Reform Project. He is also a Board member on the AMR Industry Alliance.
Dr. Frank received his doctorate in immunology at the University of Pittsburgh and pursued his postdoctoral training at the Laboratory of Viral Diseases at the National Institute of Allergy & Infectious Diseases.